Patients Coming Off Weight-Loss Medications Regain Weight Far More Rapidly Compared to Those on Conventional Diets

A recent study indicates that people who stop using new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who halt conventional lifestyle regimens.

Findings released in a prominent health publication demonstrates that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing these treatments must be aware of the potential of quick weight regain when the medication is stopped," stated expert Dr. Susan Jebb.

Such speed of recovery suggests a return to pre-treatment mass within about 18 months.

Analyzing Treatments

The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.

The team note that people who shed pounds through diet and exercise typically see a less rapid creep back—approximately 100 grams monthly—post-intervention.

The Reason for the Quick Rebound

Experts believe the way of the jabs explains the amplified rebound.

The injections copy a body's own chemical called GLP-1, which moderates hunger.

"Sustained high doses of GLP-1 levels far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means hunger is uncontrolled, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines advise the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals say that, due to the significant potential of relapse, the therapy might need to be long-term.

This opinion is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like high blood pressure.

Patient Accounts

People who have stopped the jabs describe a intense resurgence of appetite.

"It felt as if a switch that goes on and you become extremely hungry," described an individual.

This challenge is exacerbated if individuals have not developed sustainable lifestyle or habit modifications during therapy.

Significant Adoption

Survey data indicate that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.

• Use is greater among females than men.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private healthcare rather than public health services.

In conclusion, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a permanent cure and maintained weight loss hinges on combined behavioural changes.